Visual Impairment of Open Angle Glaucomas at First Presentation and after a Five to Ten Year Follow-up

References

• Anderson D. R. The optic nerve. Adler's Physiology of the Eye, 8th ed., C. V. Mosby, St. Louis 1987
   Google Scholar
• Armaly M. F. On the distribution of applanation pressure and arcuate scotoma. Drug mechanisms in glaucoma, G. Paterson, S. J.H. Miller, G. D. Paterson. Little, Brown & Co., Boston 1966
   Google Scholar
• Becker B., Morton W. R. Topical epinephrine in glaucoma suspects. Am J Ophthalmol 1966; 62: 272–277
   PubMed Web of Science ®Google Scholar
• Bengtsson B. The prevalence of glaucoma. Br J Ophthalmol 1981; 65: 46–49
   PubMed Web of Science ®Google Scholar
• Cartwright M. J., Anderson D. R. Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma). Arch Ophthalmol 1988; 106: 898–900
   PubMedGoogle Scholar
• Chandler P. A. Long-term results in glaucoma therapy. Am J Ophthalmol 1960; 49: 221–246
   Web of Science ®Google Scholar
• Gloor B. P., Dimitrakos S. A., Rabineau P. A. Long-term follow-up of glaucomatous fields by computerized (OCTOPUS) perimetry. Glaucoma Update III, Krieglstein. Springer-Verlag, Berlin-Heidelberg 1987; 123–138
   Google Scholar
• Grant W. M., Burke J. F. Why do some people go blind from glaucoma?. Ophthalmology 1982; 89: 991–998
   PubMed Web of Science ®Google Scholar
• Haas A., Flammer J., Schneider U. Influence of age on the visual fields of normal subjects. Am J Ophthalmol 1986; 101: 199–203
   PubMed Web of Science ®Google Scholar
• Harbin T. S., Podos S. M., Kolker A. E., Becker B. Visual field progression in open-angle glaucoma patients presenting with monocular field loss. Trans Am Acad Ophthalmol & Otolaryngol 1976; 81: 253–257
   Google Scholar
• Hart W. M., Jr., Becker B. The onset and evolution of glaucomatous visual field defect. Ophthalmology 1982; 89: 268–279
   PubMed Web of Science ®Google Scholar
• Heijl A., Lindgren G., Olsson J. Normal variability of statistic perimetric threshold values across the central visual field. Arch Ophthalmol 1987; 105: 1544–1549
   PubMed Web of Science ®Google Scholar
• Hollows F. C., Graham P. A. Intraocular pressure, glaucoma and glaucoma suspects in a defined population. Br J Ophthalmol 1966; 50: 570–586
   PubMed Web of Science ®Google Scholar
• Jaffe G. J., Alvarado J. A., Juster R. P. Age-related changes of the normal visual field. Arch Ophthalmol 1986; 104: 1021–1025
   PubMed Web of Science ®Google Scholar
• Jay J. L., Murray S. B. Early trabeculectomy versus conventional management in primary open angle glaucoma. Br J Ophthalmol 1988; 72: 881–889
   PubMed Web of Science ®Google Scholar
• Kass M. A., Kolker A. E., Becker B. Prognostic factors in glaucomatous visual field loss. Arch Ophthalmol 1976; 94: 1274–1276
   PubMedGoogle Scholar
• Kass M. A., Meltzer D. W., Gordon M., Cooper D., Goldberg J. J. Compliance with topical pilocarpine treatment. Am J Ophthalmol 1986; 101: 515–523
   PubMed Web of Science ®Google Scholar
• Kass M. A., Gordon M., Morley R. E., Meltzer D. W., Goldberg J. J. Compliance with topical timolol treatment. Am J Ophthalmol 1987; 103: 188–193
   PubMed Web of Science ®Google Scholar
• Kolker A. E. Visual prognosis in advanced glaucoma: A comparison of medical and surgical therapy. Trans Am Ophthalmol Soc 1977; 75: 539–555
   PubMedGoogle Scholar
• Kronfeld P. C., McGarry H. S. Five-year follow-up of glaucomas. JAMA 1948; 136: 957–965
   Web of Science ®Google Scholar
• Leibowitz H. M., Kreuger D. E., Maunder L. R., Milton R. C., Kini M. M., Kahn H. A., Nickerson J., Pool J., Colton T. L., Ganley J. P., Loewenstein J. I., Dawber T. R. The Framingham Eye Study Monograph. Surv Ophthalmol 1980; 24: 335–610, (suppl)
   PubMed Web of Science ®Google Scholar
• Leske M. C. The epidemiology of open-angle glaucoma: A review. Am J Epidemiol 1983; 118: 166–191
   PubMed Web of Science ®Google Scholar
• Lindblom B., Thorburn W. Prevalence of visual field defects due to capsular and simple glaucoma in Hälsingland, Sweden. Acta Ophthalmol (Copenh) 1982; 60: 353–361
   Google Scholar
• Lundberg L., Wettrell K., Linnér E. Ocular hypertension. A prospective twenty-year follow-up study. Acta Ophthalmol (Copenh) 1988; 65: 705–708
   Google Scholar
• Maumenee A. E. Causes of optic nerve damage in glaucoma. Ophthalmology 1983; 90: 741–752
   PubMed Web of Science ®Google Scholar
• Miller S. J.H., Karseras A. G. Blind registration and glaucoma simplex. Br J Ophthalmol 1974; 58: 455–461
   Google Scholar
• Mincler D. S., Spaeth G. L. Optic nerve damage in glaucoma. Surv Ophthalmol 1981; 26: 128–148
   Google Scholar
• Nastri G., Pascotto F., Bifani M., Sbordone G. The role of hypertension in the genesis of glaucoma. Glaucoma 1987; 9: 109–117
   Google Scholar
• Norell S. E., Granström P. A. Self-medication with pilocarpine among out-patients in a glaucoma clinic. Br J Ophthalmol 1980; 64: 137–141
   PubMed Web of Science ®Google Scholar
• Olivius E., Thorburn W. Prognosis of glaucoma simplex and glaucoma capsulare. Acta Ophthalmol (Copenh) 1976; 56: 921–934
   Google Scholar
• Pohjanpelto P., Palva J. Ocular hypertension and glaucomatous optic nerve damage. Acta Ophthalmol (Copenh) 1974; 52: 194–200
   PubMed Web of Science ®Google Scholar
• Pohjanpelto P. Influence of exfoliation syndrome on prognosis in ocular hypertension ≤25 mm Hg. Acta Ophthalmol (Copenh) 1986; 64: 39–44
   Google Scholar
• Quigley H. A., Addicks E. M., Green W. R., Maumenee A. E. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol 1981; 99: 635–649
   PubMed Web of Science ®Google Scholar
• Quigley H. A., Addicks E. M., Green W. R. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fibre loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol 1982; 100: 135–146
   PubMedGoogle Scholar
• Quigley H. A., Hohman R. M., Addicks E. M., Massof R. W., Green W. R. Morphological changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol 1983; 95: 673–691
   PubMed Web of Science ®Google Scholar
• Quigley H. A. Reappraisal of the mechanisms of glaucomatous optic nerve damage. Eye 1987; 1: 318–322
   Google Scholar
• Schappert-Kimmijser J. A five year follow-up of subjects with intraocular pressure of 22–30 mm Hg. Ophthalmologica 1971; 162: 289–295
   Google Scholar
• Shields M. B. The optic nerve head. Shields Textbook of Glaucoma, 2nd ed. Williams & Wilkins, Baltimore 1987
   Google Scholar
• Shin D. H., Kolker A. E., Kass M. A., Kabach M. B., Becker B. Long-term epinephrine therapy of ocular hypertension. Arch Ophthalmol 1976; 94: 2059–2060
   PubMed Web of Science ®Google Scholar
• Spaeth G. L. Visual loss in a glaucoma clinic. I. Sociological considerations. Invest Ophthalmol 1970; 9: 73–82
   PubMedGoogle Scholar
• Thorburn W. The outcome of visual function in capsular glaucoma. Acta Ophthalmol (Copenh) Suppl 1988; 184: 132–137
   Google Scholar
• Werner E. B., Drance S. M., Schultzer M. Trabeculectomy and the progression of glaucomatous visual field loss. Arch Ophthalmol 1977; 95: 1374–1377
   PubMedGoogle Scholar
• Wilson J., Walker A. M., Dueker D. K., Cricks R. P. Risk factors for rate of progression of glaucomatous visual field loss. Arch Ophthalmol 1982; 100: 737–741
   PubMed Web of Science ®Google Scholar